DERMALASER® 

The Erchonia DERMALASER® is the FIRST and ONLY Low-Level Laser (3LT®) to be given FDA market clearance for the treatment of acne.

The Erchonia DERMALASER® is a low-level or cold laser that works by killing the bacteria P. Acnes that causes acne. Unlike current acne-laser treatments, the Erchonia DERMALASER® is not high density, or hot, so it does not irritate or adversely affect the healthy skin cells. The Erchonia DERMALASER® targets only the acne-causing bacteria itself, not the skin, so it effectively treats the cause of acne at its root.

Up until now, people with acne have had to rely on strong antibiotic treatments lasting several months, harsh topical ointments that can irritate and severely dry out the skin or hot lasers that cause redness and pain. 30 years of research shows that side affects from low-level laser treatments of all kinds are minimal to non-existent and the DERMALASER® is no exception.

"This FDA market clearance is a major step forward in the fight against acne and the misery it causes teens and adults alike," comments Charlie Shanks, VP of Sales and Marketing for Erchonia.  "For the first time it is possible to painlessly and quickly treat the root causes of acne, instead of the usual symptomatic treatments of messy ointments and creams."